Selection and use of lactic acid bacteria for reducing inflammation caused by Helicobacter
0 Assignments
0 Petitions
Accused Products
Abstract
Strains of Lactobacillus which have been selected for their capability of reducing gastrointestinal inflammation, such as that due to Helicobacter pylori, and products derived from these strains, including agents for treatment or prophylaxis of inflammation associated with Helicobacter pylori for administration to humans and include conditioned media in which the selected strains have grown and protein-containing extracts of the conditioned media.
4 Citations
23 Claims
-
1. (canceled)
-
2. (canceled)
-
3. A biologically pure culture of a Lactobacillus strain selected for its ability to reduce gastrointestinal inflammation associated with Helicobacter pylori infection in the gastrointestinal tract in mammals using a [mouse] macrophage assay for TNFα
- activity.
-
4. (canceled)
-
5. (canceled)
-
6. (canceled)
-
7. (canceled)
-
8. (canceled)
-
9. (canceled)
-
10. (canceled)
-
11. (canceled)
-
12. (canceled)
-
13. (canceled)
-
14. (canceled)
-
15. (canceled)
-
16. (canceled)
-
17. (canceled)
-
18. (canceled)
-
19. (canceled)
-
20. (canceled)
-
21. (canceled)
-
22. (canceled)
-
23. (canceled)
Specification